Cancer progression cycling cell cycle. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Cell Line, Tumor Tumor Cells, Cultured Cell Line Prostate Cell Nucleus Cells, Cultured Epithelial Cells HeLa Cells Fibroblasts Neoplastic Stem Cells Breast HCT116 Cells Mammary Glands, Human MCF-7 Cells Stromal Cells HT29 Cells Cytoplasm

Organisms7

Mice, Nude Mice, Transgenic Mice, SCID Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Saccharomyces cerevisiae

Diseases39

Disease Progression Prostatic Neoplasms Breast Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Neoplasms Cell Transformation, Neoplastic Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Stomach Neoplasms Adenocarcinoma Carcinoma Neovascularization, Pathologic Colorectal Neoplasms Carcinoma, Squamous Cell Urinary Bladder Neoplasms Neoplastic Processes Disease Models, Animal Mammary Neoplasms, Experimental Uterine Cervical Neoplasms Precancerous Conditions Neoplasms, Hormone-Dependent Carcinoma, Non-Small-Cell Lung Liver Neoplasms Genetic Predisposition to Disease Neoplasm Recurrence, Local Bone Neoplasms Melanoma Mouth Neoplasms Carcinogenesis Neoplasms, Glandular and Epithelial Skin Neoplasms Carcinoma, Intraductal, Noninfiltrating Esophageal Neoplasms Head and Neck Neoplasms Carcinoma in Situ Endometrial Neoplasms

Chemicals and Drugs83

Cell Cycle Proteins RNA, Messenger Tumor Suppressor Protein p53 Neoplasm Proteins Cyclins Tumor Markers, Biological Antineoplastic Agents RNA, Small Interfering Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Transcription Factors Retinoblastoma Protein Cyclin-Dependent Kinase Inhibitor p21 Protein-Serine-Threonine Kinases DNA-Binding Proteins Nuclear Proteins Cyclin D1 Proto-Oncogene Proteins DNA, Neoplasm Receptors, Androgen CDC2 Protein Kinase Androgens Cyclin-Dependent Kinase 2 MicroRNAs Cyclin E Receptors, Estrogen Cyclin A Cyclin-Dependent Kinase 4 Proto-Oncogene Proteins c-akt Cyclin B Enzyme Inhibitors Receptor, erbB-2 Cadherins Antineoplastic Agents, Phytogenic DNA Prostate-Specific Antigen DNA Primers Carrier Proteins CDC2-CDC28 Kinases RNA, Neoplasm Proto-Oncogene Proteins c-myc Cyclin-Dependent Kinase Inhibitor p16 Repressor Proteins Cancer Vaccines E2F Transcription Factors Histones Receptor, Epidermal Growth Factor Cyclin B1 Microtubule-Associated Proteins beta Catenin Protein Kinases cdc25 Phosphatases Cyclin D Cisplatin Protein Kinase Inhibitors Membrane Proteins Anticarcinogenic Agents Antigens, Neoplasm E2F1 Transcription Factor Tamoxifen Transforming Growth Factor beta Ki-67 Antigen Vascular Endothelial Growth Factor A Antibodies, Monoclonal PTEN Phosphohydrolase Intracellular Signaling Peptides and Proteins Proto-Oncogene Proteins c-bcl-2 Bromodeoxyuridine Trans-Activators Proteins Recombinant Fusion Proteins Phosphatidylinositol 3-Kinases Oncogene Proteins Proliferating Cell Nuclear Antigen Paclitaxel Estrogen Receptor alpha Fluorouracil Antineoplastic Agents, Hormonal Receptors, Progesterone ras Proteins Protein Isoforms Saccharomyces cerevisiae Proteins Estrogens

Analytical, Diagnostic and Therapeutic Techniques and Equipment47

Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Immunohistochemistry Early Detection of Cancer Models, Biological Prognosis Oligonucleotide Array Sequence Analysis Flow Cytometry Neoplasm Transplantation Transfection Transplantation, Heterologous Neoplasm Staging Xenograft Model Antitumor Assays Gene Knockdown Techniques Survival Analysis Disease Models, Animal Survival Rate Mammary Neoplasms, Experimental Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Tumor Burden Tissue Array Analysis Disease-Free Survival Retrospective Studies Polymerase Chain Reaction Prospective Studies Molecular Targeted Therapy Treatment Outcome Kaplan-Meier Estimate Immunoenzyme Techniques Real-Time Polymerase Chain Reaction Risk Factors Immunoblotting Microscopy, Fluorescence Drug Screening Assays, Antitumor Risk Neoplasm Grading Fluorescent Antibody Technique Risk Assessment Combined Modality Therapy Predictive Value of Tests Reproducibility of Results Sensitivity and Specificity Multivariate Analysis Immunoprecipitation Orchiectomy

Phenomena and Processes63

Cell Cycle Gene Expression Regulation, Neoplastic Cell Proliferation Cell Cycle Checkpoints Cell Division G1 Phase Signal Transduction Apoptosis Mitosis S Phase Mutation Cell Movement Phosphorylation Down-Regulation G2 Phase Cell Survival Time Factors RNA Interference Up-Regulation Transfection Promoter Regions, Genetic Menstrual Cycle Base Sequence Epithelial-Mesenchymal Transition DNA Damage Drug Resistance, Neoplasm G2 Phase Cell Cycle Checkpoints Phenotype G1 Phase Cell Cycle Checkpoints Transcription, Genetic Tumor Microenvironment Gene Expression Gene Silencing G0 Phase Cell Differentiation DNA Methylation Cell Growth Processes Protein Binding Gene Expression Regulation DNA Replication Genes, Tumor Suppressor Dose-Response Relationship, Drug Amino Acid Sequence Genes, cdc Enzyme Activation Interphase Genetic Predisposition to Disease Cell Adhesion Genes, p53 Genotype Epigenesis, Genetic DNA Repair Genes, Neoplasm Risk Transcriptional Activation Estrous Cycle Cell Aging MAP Kinase Signaling System Alleles Gene Deletion Sensitivity and Specificity Genes, ras Oncogenes

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Molecular Sequence Data Base Sequence Survival Rate Amino Acid Sequence

Health Care15

Survival Analysis Survival Rate Follow-Up Studies Disease-Free Survival Retrospective Studies Prospective Studies Treatment Outcome Kaplan-Meier Estimate Risk Factors Risk Risk Assessment Predictive Value of Tests Reproducibility of Results Sensitivity and Specificity Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Cell Cycle Disease Progression Cell Cycle Proteins Cell Line, Tumor Prostatic Neoplasms Gene Expression Regulation, Neoplastic Breast Neoplasms Cell Proliferation Neoplasm Invasiveness Cell Cycle Checkpoints Neoplasm Metastasis Neoplasms Cell Division G1 Phase Signal Transduction Apoptosis Mice, Nude Mitosis S Phase RNA, Messenger Cell Transformation, Neoplastic Lung Neoplasms Gene Expression Profiling Tumor Suppressor Protein p53 Neoplasm Proteins Cyclins Reverse Transcriptase Polymerase Chain Reaction Mutation Blotting, Western Tumor Markers, Biological Cell Movement Tumor Cells, Cultured Antineoplastic Agents Colonic Neoplasms Ovarian Neoplasms Phosphorylation RNA, Small Interfering Immunohistochemistry Early Detection of Cancer Models, Biological Prognosis Tumor Suppressor Proteins Down-Regulation Cyclin-Dependent Kinase Inhibitor p27 Transcription Factors G2 Phase Retinoblastoma Protein Cyclin-Dependent Kinase Inhibitor p21 Protein-Serine-Threonine Kinases DNA-Binding Proteins Molecular Sequence Data Cell Line Pancreatic Neoplasms Oligonucleotide Array Sequence Analysis Stomach Neoplasms Nuclear Proteins Cell Survival Flow Cytometry Cyclin D1 Neoplasm Transplantation Time Factors Adenocarcinoma RNA Interference Up-Regulation Transfection Carcinoma Promoter Regions, Genetic Transplantation, Heterologous Menstrual Cycle Base Sequence Epithelial-Mesenchymal Transition DNA Damage Neovascularization, Pathologic Colorectal Neoplasms Drug Resistance, Neoplasm Prostate Neoplasm Staging G2 Phase Cell Cycle Checkpoints Xenograft Model Antitumor Assays Phenotype Cell Nucleus G1 Phase Cell Cycle Checkpoints Transcription, Genetic Carcinoma, Squamous Cell Gene Knockdown Techniques Tumor Microenvironment Urinary Bladder Neoplasms Cells, Cultured Survival Analysis Proto-Oncogene Proteins Gene Expression DNA, Neoplasm Receptors, Androgen Gene Silencing Epithelial Cells Neoplastic Processes G0 Phase CDC2 Protein Kinase Disease Models, Animal Androgens

No FAQ available that match "cancer progression cycling cell cycle"